Melbourne, Australia, Sept. 18, 2017 – Telix Pharmaceuticals Limited (“Telix”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have been appointed to the Board of Telix Pharmaceuticals Limited as Non-Executive Directors. Mr. McCann will also serve in the capacity of Chairman. To read the full press release click here.